1. Home
  2. IRWD vs PFO Comparison

IRWD vs PFO Comparison

Compare IRWD & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • PFO
  • Stock Information
  • Founded
  • IRWD 1998
  • PFO 1991
  • Country
  • IRWD United States
  • PFO United States
  • Employees
  • IRWD N/A
  • PFO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • PFO Finance Companies
  • Sector
  • IRWD Health Care
  • PFO Finance
  • Exchange
  • IRWD Nasdaq
  • PFO Nasdaq
  • Market Cap
  • IRWD 111.2M
  • PFO 121.4M
  • IPO Year
  • IRWD 2010
  • PFO N/A
  • Fundamental
  • Price
  • IRWD $1.13
  • PFO $9.46
  • Analyst Decision
  • IRWD Buy
  • PFO
  • Analyst Count
  • IRWD 5
  • PFO 0
  • Target Price
  • IRWD $4.94
  • PFO N/A
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • PFO 31.8K
  • Earning Date
  • IRWD 11-06-2025
  • PFO 01-01-0001
  • Dividend Yield
  • IRWD N/A
  • PFO 6.51%
  • EPS Growth
  • IRWD N/A
  • PFO N/A
  • EPS
  • IRWD N/A
  • PFO N/A
  • Revenue
  • IRWD $308,519,000.00
  • PFO N/A
  • Revenue This Year
  • IRWD N/A
  • PFO N/A
  • Revenue Next Year
  • IRWD N/A
  • PFO N/A
  • P/E Ratio
  • IRWD N/A
  • PFO N/A
  • Revenue Growth
  • IRWD N/A
  • PFO N/A
  • 52 Week Low
  • IRWD $0.53
  • PFO $6.90
  • 52 Week High
  • IRWD $5.13
  • PFO $8.51
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 52.75
  • PFO 73.70
  • Support Level
  • IRWD $1.01
  • PFO $9.27
  • Resistance Level
  • IRWD $1.35
  • PFO $9.31
  • Average True Range (ATR)
  • IRWD 0.10
  • PFO 0.05
  • MACD
  • IRWD -0.02
  • PFO 0.02
  • Stochastic Oscillator
  • IRWD 33.33
  • PFO 91.38

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: